Mednax Inc (MD) Receives Analyst Rating

Mednax Inc (MD) : The consensus on Mednax Inc (MD) based on 11 analyst recommendation on the company stock is 2, which is interpreted as a Buy recommendation. Zacks Investment Research has issued a rank of 3 which endorses a Hold on the stock. However, 5 brokers have a differing view as they consider the stock to be a Strong Buy at current levels. 1 analyst believes that the stock is a Buy, which can produce decent returns in the future. 5 experts consider that the stocks earnings and the quoted price is in harmony, hence, they give it a Hold rating.

Mednax Inc (MD) : The highest short term price target forecast on Mednax Inc (MD) is $80 and the lowest target price is $70. A total of 7 equity analysts are currently covering the company. The average price of all the analysts is $75.71 with a standard deviation of $3.25.


Also, Equity Analysts at the Brokerage Firm, Jefferies, maintains their rating on the shares of Mednax Inc (NYSE:MD). Jefferies has a Buy rating on the shares. As per the latest research report, the brokerage house lowers the price target to $75 per share from a prior target of $80. The rating by the firm was issued on August 26, 2016.

Mednax Inc (NYSE:MD): After opening at $64.85, the stock dipped to an intraday low of $64.24 on Thursday. However, the bulls stepped in to buy at lower levels and pushed the stock higher. The stock touched an intraday high of $65.65 and the buying power remained strong till the end. The stock closed at $65.26 for the day, a gain of 0.32% for the day session. The total traded volume was 681,169. The stocks close on the previous trading day was $65.05.

MEDNAX, Inc. (MEDNAX) is a provider of physician services, including newborn, maternal-fetal and other pediatric subspecialty care. The Company provides clinical care to babies born prematurely or with complications within specific hospital units, primarily neonatal intensive care units (NICUs). It provides anesthesia care at more than 90 hospitals, 100 ambulatory surgery centers and office-based practices with over 950 of its affiliated anesthesiologists. It provides acute and chronic pain management services in over 20 pain management centers through its network of physicians and physician assistants. It provides inpatient and office-based clinical care to expectant mothers and their unborn babies through its over 245 affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians. Its network includes other pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists and pediatric surgeons.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.